Skip to content
My WebMD Sign In, Sign Up
Font Size

Prostate Cancer: PSA Change May Be Key to Risk

Researchers Say Tracking PSA Changes Indicates Who's at Risk of Dying When Cancer Returns
By
WebMD Health News

July 26, 2005 -- What's the risk of dying when prostate cancer comes back after treatment? Two new studies point to who's at high risk and who isn't.

A crucial difference, the two new studies suggest, is how fast blood levels of prostate-specific antigen (PSA) go up.

Anthony V. D'Amico, MD, PhD, chief of genitourinary radiation oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute, led a study of 358 men who underwent radiation therapy. His team looked at whether prediagnosis changes in PSA predicted a man's risk of dying from prostate cancer. The findings confirmed the results of an earlier study of men who underwent prostate surgery.

"The best use of PSA is not to look at the number but to look at the trend over time," D'Amico tells WebMD.

Stephen J. Freedland, MD, clinical instructor in urology at Johns Hopkins University, led a team that gathered data on 379 men who underwent prostate surgery but had their cancer come back.

"These studies show that looking at changes in PSA are more important than a single value," Freedland tells WebMD. "One PSA result is like looking at a snapshot of a horse race and trying to determine who will win. Looking at snapshots over time gives you a better idea."

Both studies appear in the July 27 issue of The Journal of the American Medical Association.

PSA Velocity

PSA is a chemical marker on the outside of prostate cells. As prostate cancer cells increase in number, blood PSA levels rise.

But PSA levels in and of themselves aren't a reliable indicator of cancer. Blood levels of PSA go up for other reasons besides cancer. And very deadly prostate cancers can occur even at low PSA levels.

"There has been controversy over what is the best use of PSA as a screening tool and what is the best use of the test as a tool to guide treatment," D'Amico says.

Instead of simply testing once for PSA and deciding that it is "high" or "normal," D'Amico says it appears to be more useful to test at regular intervals. This gives a reading on PSA change -- what doctors call PSA velocity.

"Our study shows that men who experience a two-point rise in PSA in the year preceding a diagnosis of prostate cancer -- despite a low level of PSA and despite a biopsy showing a supposedly 'favorable' prostate cancer -- have more aggressive cancer and need more aggressive treatment to cure it."

Men whose PSA levels rose more than two points in a year had a 12-fold higher risk of dying from prostate cancer than men whose PSA levels rose less quickly.

"The median survival for rapid risers is only six years, and that is very short for prostate cancer," D'Amico says. "The bottom line for patients is this: Get a PSA test annually and know the result. Because even if your doctor isn't looking at year-to-year change, at least you can. We recommend getting a baseline PSA test at age 35, especially for men whose dads had prostate cancer."

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
woman speaking with doctor
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW